98%
921
2 minutes
20
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern among children and adolescents. This study aims to evaluate the diagnostic value of ultrasound derived fat fraction (uDFF) in quantifying liver fat in children with MASLD and to explore the correlation between uDFF values and various anthropometric and biochemical parameters.
Methods: This cross-sectional study included 230 children diagnosed with steatotic liver via ultrasound and 38 healthy controls. Physical examinations, laboratory tests, and abdominal ultrasound examination were conducted.
Results: The study included 168 boys and 62 girls in MASLD group, with an average age of 9.8 years. Significant differences were observed in waist circumference, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels between boys and girls. Among the 230 children with MASLD, 191 in the Grade 1 MASLD group came with a mean uDFF value of 11.52% and 39 in the Grade 2 MASLD group came with a mean uDFF value of 19.10%, and there was a significant difference in the uDFF values when comparing between the two groups (P<0.001). As the severity of steatotic liver increased, measurements of ultrasound-guided attenuation parameter (UGAP) and uDFF also rose. Lipid parameters and liver enzymes were significant associated with UGAP and uDFF in boys, but not in girls. The uDFF values of the children with MASLD were positively correlated with weight (P<0.001), waist (P<0.001), body mass index (BMI) (P=0.001), fasting blood glucose (P=0.008), ALT (P<0.001) and AST (P<0.001).
Conclusions: Ultrasound-derived fat fraction technique has high diagnostic value in noninvasive quantitative assessment of hepatic steatosis in children with MASLD and reflects fat metabolism to some extent.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209668 | PMC |
http://dx.doi.org/10.21037/qims-24-2393 | DOI Listing |
Crit Rev Food Sci Nutr
September 2025
Hunan Key Laboratory of Deep Processing and Quality Control of Cereals and Oils, State Key Laboratory of Utilization of Woody Oil Resource, College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, China.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition that results from metabolic disorders. In addition to genetic factors, irregular and high-energy diets may also significantly contribute to its pathogenesis. Dietary habits can profoundly alter the composition of gut microbiota and metabolites.
View Article and Find Full Text PDFCell Mol Life Sci
September 2025
Department of Gastroenterology, The Second Hospital of Shandong University, Jinan, China.
Metabolic associated steatohepatitis (MASH) is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by hepatocellular injury, inflammation, and fibrosis. Despite advances in understanding its pathophysiology, the molecular mechanisms driving MASH progression remain unclear. This study investigates the role of long non-coding RNA Linc01271 in MASLD/MASH pathogenesis, ant its involvement in the miR-149-3p/RAB35 axis and PI3K/AKT/mTOR signaling pathway.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Technion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.
The coexistence of chronic hepatitis B (CHB) and metabolic dysfunction-associated liver disease (MASLD) gained recognition, but the diagnostic performance of non-invasive markers regarding it remains underexplored. This study aimed to evaluate the utility of the FIB-4 index for fibrosis prediction in CHB patients and investigate its performance in the distinct subgroup of CHB-MASLD. A prospective study from 2021 to 2022 included 109 CHB and 64 CHB-MASLD patients.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Chronic liver disease (CLD) is a leading cause of global morbidity and mortality, necessitating effective preventive strategies. Growing evidence is linking coffee consumption with reduced risk of disease progression in various CLDs, including metabolic dysfunction associated steatotic liver disease (MASLD), alcoholic liver disease, hepatitis B and C, autoimmune hepatitis, and a reduction in the risk of hepatocellular carcinoma development. Coffee, a globally consumed beverage, contains bioactive compounds like caffeine, chlorogenic acids, diterpenes, and polyphenols, which may offer hepatoprotective benefits through anti-inflammatory, antioxidant, and metabolic regulatory effects.
View Article and Find Full Text PDFLiver Int
October 2025
The Global NASH Council, Washington, DC, USA.
Background: The Middle East and North Africa (MENA) region is undergoing demographic shifts potentially increasing metabolic dysfunction-associated steatotic liver disease (MASLD) and its complications. We assessed MASLD prevalence and liver disease burden from 2010 to 2021.
Methods: Data from Global Burden of Disease (GBD), United Nations Population Division and NCD Risk Factor Collaboration covering 21 MENA countries were used for annual percent change (APC) trends per Joinpoint regression.